BioStock: New patent strengthens WntResearch

WntResearch has recently been granted a new substance patent in Europe for the company’s drug candidate Foxy-5, for the treatment of colon cancer. The patent relates to a new, more soluble salt of the drug candidate Foxy-5 and extends the patent protection until 2041. BioStock reached out to CEO Pernilla Sandwall to find out more about this milestone.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/10/new-patent-strengthens-wntresearch/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se